Healthcare -
Biotechnology - NASDAQ - US
$ 34.06
0.889 %
$ 13.1 B
Market Cap
-5.86
P/E
Price Target
Average
262.91%
Revenue Forecast
Estimate
--5.82%
EBIT
Estimate
28.90%
Net Income
Estimate
38.51%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Moderna, Inc.
Wall Street analysts predict an average 1-year price target for MRNA of $124 , with forecasts ranging from
a
low of
$55 to a high of $310 .
MRNA Lowest Price Target
Wall Street Target
55 USD
61.48%
MRNA Average Price Target
Wall Street Target
124 USD
262.91%
MRNA Highest Price Target
Wall Street Target
310 USD
810.16%
REVENUE FORECAST
Revenue Forecast Chart MRNA
EBIT FORECAST
EBIT Forecast Chart MRNA
NET INCOME FORECAST
Net Income Chart MRNA